Surmodics reported $10.93M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Anika Therapeutics ANIK:US 35.34M 111K
Baxter International BAX:US $ 2663M 115M
Bioscrip BIOS:US $ 231.77M 14.58M
Cryolife CRY:US $ 74.32M 1.89M
Edwards Lifesciences EW:US $ 740M 9.4M
Haemonetics HAE:US $ 277.89M 15.14M
Heron Therapeutics HRTX:US $ 61.32M 4.85M
Mesa Laboratories MLAB:US $ 26.87M 2.27M
Nektar Therapeutics NKTR:US $ 16.97M 1.59M
Stryker SYK:US $ 3749M 224M
Surmodics SRDX:US $ 10.93M 1.46M